The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| JOUNCE THERAPEUTICS, INC. | COM | 481116101 | 64,402 | 9,200,349 | SH | DFND | 1,2,3 | 9,200,349 | 0 | 0 | |
| ALLENA PHARMACEUTICALS, INC. | COM | 018119107 | 3,572 | 2,790,964 | SH | DFND | 1,2,3 | 2,790,964 | 0 | 0 | |
| REVOLUTION MEDICINES, INC. | COM | 76155X100 | 75,590 | 1,909,317 | SH | DFND | 1,2,3 | 1,909,317 | 0 | 0 | |